Perspective Therapeutics (CATX) Total Non-Current Liabilities (2011 - 2026)

Perspective Therapeutics has disclosed Total Non-Current Liabilities across 16 years of filings, most recently posting $67.7 million for Q2 2026.

• In Q2 2026, Total Non-Current Liabilities rose 51.19% year-over-year to $67.7 million; the TTM figure through Jun 2026 stood at $67.7 million (up 51.19% YoY), while the FY2025 annual figure was $59.6 million, up 18.22% from the prior year.
• Total Non-Current Liabilities came in at $67.7 million for Q2 2026 at Perspective Therapeutics, up from $62.9 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $67.7 million in Q2 2026 to a low of $2.3 million in Q1 2022.
• Average Total Non-Current Liabilities over 5 years is $32.6 million, with a median of $44.6 million recorded in 2025.
• Year-over-year, Total Non-Current Liabilities soared 713.47% in 2023 and declined 16.57% in 2025.
• Over 5 years, Total Non-Current Liabilities stood at $2.8 million in 2022, then soared by 713.47% to $22.7 million in 2023, then surged by 121.81% to $50.4 million in 2024, then increased by 18.22% to $59.6 million in 2025, then gained by 13.6% to $67.7 million in 2026.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $67.7 million in Q2 2026, $62.9 million in Q1 2026, and $59.6 million in Q4 2025.